Gilead’s Covid-19 Drug May Offer ‘Ray of Hope,’ Street Says

(Bloomberg) -- Gilead Sciences Inc. rose Monday after results from a small set of Covid-19 patients getting the experimental therapy remdesivir. While acknowledging it was too early to tell if the ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.